These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6788704)

  • 21. Quantitation and identification of antibodies to outer-membrane proteins of Pseudomonas aeruginosa in sera of patients with cystic fibrosis.
    Hancock RE; Mouat EC; Speert DP
    J Infect Dis; 1984 Feb; 149(2):220-6. PubMed ID: 6421943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of antibodies to Pseudomonas aeruginosa in serum and oral fluid from patients with cystic fibrosis.
    Weisner AM; Chart H; Bush A; Davies JC; Pitt TL
    J Med Microbiol; 2007 May; 56(Pt 5):670-674. PubMed ID: 17446292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative studies on immunologically specific and non-specific absorption of Pseudomonas aeruginosa antibodies in serum from cystic fibrosis patients.
    Høiby N; Hertz JB
    Acta Pathol Microbiol Scand C; 1981 Jun; 89(3):185-92. PubMed ID: 6797245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies to proteases and exotoxin A of Pseudomonas aeruginosa in patients with cystic fibrosis: Demonstration by radioimmunoassay.
    Klinger JD; Straus DC; Hilton CB; Bass JA
    J Infect Dis; 1978 Jul; 138(1):49-8. PubMed ID: 98596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between specific IgG subclass antibodies to Pseudomonas aeruginosa and opsonic activity in serum from patients with cystic fibrosis.
    Pressler T; Jensen ET; Espersen F; Pedersen SS; Høiby N; Koch C
    Pediatr Pulmonol; 1994 Jan; 17(1):31-40. PubMed ID: 8108174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bactericidal activity of serum from cystic fibrosis patients for Pseudomonas aeruginosa.
    Penketh AR; Pitt TL; Hodson ME; Batten JC
    J Med Microbiol; 1983 Nov; 16(4):401-8. PubMed ID: 6417338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secretory IgA response against Pseudomonas aeruginosa in the upper airways and the link with chronic lung infection in cystic fibrosis.
    Mauch RM; Rossi CL; Aiello TB; Ribeiro JD; Ribeiro AF; Høiby N; Levy CE
    Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28645157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies to cell envelope proteins of Pseudomonas aeruginosa in cystic fibrosis patients.
    Fernandes PB; Kim C; Cundy KR; Haung NN
    Infect Immun; 1981 Aug; 33(2):527-32. PubMed ID: 6792080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serogroups of Pseudomonas aeruginosa and the immune response of patients with cystic fibrosis.
    Diaz E; Mosovich LL; Neter E
    J Infect Dis; 1970 Mar; 121(3):269-74. PubMed ID: 4984335
    [No Abstract]   [Full Text] [Related]  

  • 30. Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis.
    Döring G; Høiby N
    Infect Immun; 1983 Oct; 42(1):197-201. PubMed ID: 6413411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross-sectional and longitudinal studies of naturally occurring antibodies to Pseudomonas aeruginosa in cystic fibrosis indicate absence of antibody-mediated protection and decline in opsonic quality after infection.
    Tosi MF; Zakem-Cloud H; Demko CA; Schreiber JR; Stern RC; Konstan MW; Berger M
    J Infect Dis; 1995 Aug; 172(2):453-61. PubMed ID: 7622889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoglobulin A and immunoglobulin G antibody responses to alginates from Pseudomonas aeruginosa in patients with cystic fibrosis.
    Pedersen SS; Espersen F; Høiby N; Jensen T
    J Clin Microbiol; 1990 Apr; 28(4):747-55. PubMed ID: 2110181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteases of Pseudomonas aeruginosa in patients with cystic fibrosis.
    Döring G; Obernesser HJ; Botzenhart K; Flehmig B; Høiby N; Hofmann A
    J Infect Dis; 1983 Apr; 147(4):744-50. PubMed ID: 6404993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IgG subclass antibodies to Pseudomonas aeruginosa in sera from patients with chronic Ps. aeruginosa infection investigated by ELISA.
    Pressler T; Pedersen SS; Espersen F; Høiby N; Koch C
    Clin Exp Immunol; 1990 Sep; 81(3):428-34. PubMed ID: 2118845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotype-specific serum IgG antibodies to lipopolysaccharides of Pseudomonas aeruginosa in cystic fibrosis: correlation to disease, subclass distribution, and experimental protective capacity.
    Schaad UB; Lang AB; Wedgwood J; Buehlamnn U; Fuerer E
    Pediatr Res; 1990 May; 27(5):508-13. PubMed ID: 2111907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IgG antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis.
    Cordon SM; Elborn JS; Rayner RJ; Hiller EJ; Shale DJ
    Arch Dis Child; 1992 Jun; 67(6):737-40. PubMed ID: 1626995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenic mechanisms of chronic Pseudomonas aeruginosa infections in cystic fibrosis patients.
    Høiby N; Döring G; Schiøtz PO
    Antibiot Chemother (1971); 1987; 39():60-76. PubMed ID: 3118792
    [No Abstract]   [Full Text] [Related]  

  • 38. Development of enzyme linked immunosorbent assay (ELISA) to detect antibodies to Pseudomonas aeruginosa cell surface antigens in sera of patients with cystic fibrosis.
    Brett MM; Ghoneim AT; Littlewood JM; Losowsky MS
    J Clin Pathol; 1986 Oct; 39(10):1124-9. PubMed ID: 3097080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of antibody in infections due to Pseudomonas aeruginosa.
    Young LS
    J Infect Dis; 1974 Nov; 130 Suppl(0):S111-8. PubMed ID: 4213568
    [No Abstract]   [Full Text] [Related]  

  • 40. Relative increase in IgG antibodies to Pseudomonas aeruginosa 60-kDa GroEL in prediabetic patients with cystic fibrosis.
    Jensen P; Johansen HK; Lanng S; Høiby N
    Pediatr Res; 2001 Mar; 49(3):423-8. PubMed ID: 11228271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.